Immunological Medicines for Poultry
Immunological veterinary medicinal products, including vaccines, are authorised for poultry.
Name
|
Description
|
Marketing Authorisation Holder
|
License Number
|
License Date
|
Animal
|
Further Information
|
Vectormune ND
|
Marek'sche Krankheit, Newcastle-Krankheit
|
CEVA-Phylaxia Co. Ltd., Ungarn
|
EU/2/15/188 |
08.09.2015 |
Huhn |
EPAR: Vectormune ND
|
Vectormune FP ILT + AE
|
Hühnerpocken, Aviäre Infektiöse Laryngotracheitis, Aviäre Enzephalomyelitis
|
CEVA-Phylaxia Co. Ltd., Ungarn
|
EU/2/20/250 |
24.04.2020 |
Huhn |
|
Vectormune FP ILT
|
Hühnerpocken, Infektiöse Laryngotracheitis
|
Ceva-Phylaxia Co. Ltd., Ungarn
|
EU/2/20/266 |
09.12.2020 |
Huhn |
|
Vaxxitek HVT + IBD
|
Infektiöse Bursitis,
Marek'sche Krankheit
|
Boehringer Ingelheim Vetmedica GmbH
|
EU/2/02/032/001 |
13.08.2002 |
Huhn |
EPAR: Vaxxitek HVT + IBD
|
Ultifend ND IBD
|
Newcastle-Krankheit, Infektiöse Bursitis, Marek'sche Krankheit
|
Ceva-Phylaxia Co. Ltd., Ungarn
|
EU/2/21/272 |
20.04.2021 |
Huhn |
|
Trituren
|
Newcastle Disease,
Paramyxovirose der Pute,
Infektiöse Rhinotracheitis
|
Boehringer Ingelheim Vetmedica GmbH
|
38a/92 |
27.12.1994 |
Pute |
PharmNet.Bund
|
Terivac
|
Infektiöse Rhinotracheitis
|
Boehringer Ingelheim Vetmedica GmbH
|
106a/90 |
18.11.1998 |
Pute |
PharmNet.Bund
|
RP Vacc
|
Paramyxovirose der Taube, Rotavirus-Infektion der Taube
|
Pharmagal Bio, spol.s.r.o., Slowakei
|
PEI.V.12101.01.1 |
06.12.2021 |
Taube |
PharmNet.Bund
|
PRIMUN SALMONELLA T
|
Salmonellen-Infektion
|
Laboratorios Calier S.A., Spanien
|
PEI.V.12106.01.1 |
13.07.2022 |
Huhn |
PharmNet.Bund
|
PRIMUN SALMONELLA E
|
Salmonellen-Infektion
|
Laboratorios Calier S.A., Spanien
|
PEI.V.11784.01.1 |
07.09.2015 |
Huhn |
PharmNet.Bund
|
PRIMUN NEWCASTLE HB1
|
Newcastle-Krankheit
|
Laboratorios Calier S.A., Spanien
|
PEI.V.11870.01.1 |
19.07.2017 |
Huhn |
PharmNet.Bund
|
PRIMUN NEWCASTLE C30
|
Newcastle-Krankheit
|
Laboratorios Calier S.A., Spanien
|
PEI.V.11935.01.1 |
29.05.2018 |
Huhn |
PharmNet.Bund
|
PRIMUN IB-ND DUO
|
Newcastle-Krankheit, Infektiöse Bronchitis
|
Laboratorios Calier S.A., Spanien
|
PEI.V.11966.01.1 |
28.01.2019 |
Huhn |
PharmNet.Bund
|
PRIMUN GUMBORO W2512
|
Infektiöse Bursitis
|
Laboratorios Calier S.A., Spanien
|
PEI.V.12107.01.1 |
10.02.2022 |
Huhn |
PharmNet.Bund
|
PRIMUN GUMBORO
|
Infektiöse Bursitis
|
Laboratorios Calier S.A., Spanien
|
PEI.V.11852.01.1 |
01.02.2019 |
Huhn |
PharmNet.Bund
|
PRIMUN BRONCHITIS H120
|
Infektiöse Bronchitis
|
Laboratorios Calier S.A., Spanien
|
PEI.V.11967.01.1 |
15.04.2019 |
Huhn |
PharmNet.Bund
|
Prevexxion RN+HVT+IBD
|
Marek‘sche Krankheit, Infektiöse Bursitis
|
Boehringer Ingelheim Vetmedica GmbH
|
EU/2/20/255 |
20.07.2020 |
Huhn |
EPAR: Prevexxion RN+HVT-IBD
|
PREVEXXION RN+HVT
|
Marek'sche Krankheit
|
Boehringer Ingelheim Vetmedica GmbH
|
EU/2/23/302 |
26.10.2023 |
Huhn |
EPAR: PREVEXXION RN+HVT
|
Prevexxion RN
|
Marek‘sche Krankheit
|
Boehringer Ingelheim Vetmedica GmbH
|
EU/2/20/254 |
20.07.2020 |
Huhn |
EPAR: Prevexxion RN
|
Poulvac TRT
|
Infektiöse Rhinotracheitis
|
Zoetis Deutschland GmbH
|
PEI.V.01721.01.1 |
05.12.2000 |
Pute |
PharmNet.Bund
|
Poulvac Procerta HVT-IBD
|
Marek'sche Krankheit, Infektiöse Bursitis
|
Zoetis Belgium
|
EU/2/23/300 |
27.10.2023 |
Huhn |
EPAR: Poulvac Procerta HVT-IBD
|
Poulvac ND Hitchner B1
|
Newcastle-Krankheit
|
Zoetis Deutschland GmbH
|
PEI.V.00375.01.1 |
22.04.1999 |
Huhn |
PharmNet.Bund
|
Poulvac MG
|
Mykoplasmen-Infektion
|
Zoetis Deutschland GmbH
|
80a/88 |
26.02.2004 |
Huhn |
PharmNet.Bund
|
Poulvac Marek CVI + HVT
|
Marek'sche Krankheit
|
Zoetis Deutschland GmbH
|
PEI.V.01271.01.1 |
31.05.2000 |
Huhn |
PharmNet.Bund
|
Poulvac IB QX
|
Infektiöse Bronchitis
|
Zoetis Deutschland GmbH
|
PEI.V.11668.01.1 |
12.04.2013 |
Huhn |
PharmNet.Bund
|
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 518 in BAnz AT 26.06.2024 B7.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.